Ethical Problems of in Vitro Fertilization

M. Macnaughton
DOI: https://doi.org/10.1177/014107688507801002
1985-10-01
Journal of the Royal Society of Medicine
Abstract:cer Project criteria (Slack 1984). Confirmation of these results by other workers is eagerly awaited. We have had the opportunity of studying the role of adrenal androgens in a group of 21 patients with disease progression, whose testicular androgen production had been ablated either by prior orchidectomy or concomitant LHRH analogue therapy. Dramatic objective responses were seen in 30% of the patients studied, suggesting that some of these tumours retain some degree of androgen dependence (Williams et al. 1985). Ketoconazole has advantages over aminoglutethimide, which also blocks adrenal androgen production, in that ketoconazole does not significantly impair cortisol production. The cortisol replacement therapy required with aminoglutethimide may account, in part, for some of the objective responses seen with this agent. Furthermore, side effects of aminoglutethimide, particularly lethargy and depression, limit the acceptability of this agent in elderly men. The early results of combination therapy aimed at total androgen ablation, using orchidectomy or LHRH to block testicular androgen production in combination with an antiandrogen or drugs such as ketoconazole or dexamethasone to block adrenal androgen formation, appear to have significant advantages over single therapy. With the further development of receptor studies, and hopefully large clinical trials using combination therapy, some significant benefits beyond just palliation should at last be seen in the treatment of this disease.
What problem does this paper attempt to address?